We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
+16.85%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$13.2B
AUM Growth
+$2.53B
(+24%)
Cap. Flow
+$1B
Cap. Flow
% of AUM
7.59%
Top 10 Holdings %
Top 10 Hldgs %
23.93%
Holding
3,118
New
401
Increased
1,400
Reduced
617
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$120M |
| 2 |
Globe Life
GL
|
+$115M |
| 3 |
MPT
Medical Properties Trust
MPT
|
+$91.5M |
| 4 |
Arch Capital
ACGL
|
+$69.2M |
| 5 |
Amazon
AMZN
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$138M |
| 2 |
GSK
GSK
|
+$98.7M |
| 3 |
Crown Holdings
CCK
|
+$92.3M |
| 4 |
American Water Works
AWK
|
+$54M |
| 5 |
SolarEdge
SEDG
|
+$45.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.64% |
| 2 | Financials | 15.05% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Communication Services | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
IDEX
IEX
$17.3B
| $1.6M | 0.01% |
8,041
+2,919
| +57% | +$555K |
|
577
ZTO Express
ZTO
$17.9B
| $1.58M | 0.01% |
54,323
+36,291
| +201% | +$1.07M |
|
578
Gabelli Dividend & Income Trust
GDV
$2.66B
| $1.58M | 0.01% |
73,504
-4,777
| -6% | -$95.6K |
|
579
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
| $1.57M | 0.01% |
25,480
+6,660
| +35% | +$407K |
|
580
Baidu
BIDU
$37.2B
| $1.57M | 0.01% |
7,247
+705
| +11% | +$105K |
|
581
Chewy
CHWY
$9.63B
| $1.56M | 0.01% |
17,420
+1,374
| +9% | +$100K |
|
|
ALXN
582
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.56M | 0.01% |
9,968
+1,771
| +22% | +$228K |
|
583
Otis Worldwide
OTIS
$28.2B
| $1.55M | 0.01% |
22,913
-283
| -1% | -$18.4K |
|
584
iShares Russell 3000 ETF
IWV
$20.4B
| $1.53M | 0.01% |
6,867
+6,379
| +1,307% | +$1.34M |
|
585
TotalEnergies
TTE
$190B
| $1.53M | 0.01% |
36,473
-458
| -1% | -$17.7K |
|
586
Tyson Foods
TSN
$20.4B
| $1.52M | 0.01% |
23,648
+6,014
| +34% | +$374K |
|
587
State Street SPDR S&P Metals & Mining ETF
XME
$4.48B
| $1.51M | 0.01% |
45,207
+43,982
| +3,590% | +$1.25M |
|
588
Darden Restaurants
DRI
$24.4B
| $1.5M | 0.01% |
12,592
+1,063
| +9% | +$114K |
|
589
W.R. Berkley
WRB
$26.6B
| $1.49M | 0.01% |
50,456
+23,496
| +87% | +$678K |
|
590
John Hancock Multifactor Large Cap ETF
JHML
$1.2B
| $1.49M | 0.01% |
31,356
+1,346
| +4% | +$60.3K |
|
591
Brookfield Renewable
BEPC
$6.26B
| $1.48M | 0.01% |
25,464
+7,536
| +42% | +$362K |
|
592
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.76B
| $1.48M | 0.01% |
10,721
+375
| +4% | +$47.9K |
|
593
American International
AIG
$41.3B
| $1.46M | 0.01% |
38,513
+10,835
| +39% | +$382K |
|
594
Synopsys
SNPS
$79.7B
| $1.45M | 0.01% |
5,606
+97
| +2% | +$22.4K |
|
595
Vanguard Extended Market ETF
VXF
$31.9B
| $1.45M | 0.01% |
8,807
+995
| +13% | +$147K |
|
596
CarMax
KMX
$8.26B
| $1.45M | 0.01% |
15,355
+9,215
| +150% | +$864K |
|
597
BHP
BHP
$230B
| $1.45M | 0.01% |
24,846
+23,332
| +1,541% | +$1.17M |
|
|
PMO
598
Franklin Municipal Opportunities Trust
PMO
$285M
| $1.44M | 0.01% |
105,351
+15,000
| +17% | +$199K |
|
599
Virtu Financial
VIRT
$4.93B
| $1.44M | 0.01% |
57,158
-641
| -1% | -$14.8K |
|
600
Dominion Energy
D
$59.3B
| $1.43M | 0.01% |
19,003
-1,852
| -9% | -$147K |
|
Similar funds
NAMI
Rockefeller Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Rockefeller Capital Management held 3,118 positions worth $13.2B, up 24% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Rockefeller Capital Management deployed $1B of net new capital in Q4 2020, opening 401 new positions and adding to 1,400 existing holdings. Its largest new stake was BridgeBio Pharma: 777,031 shares worth $55.3M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Progressive, an estimated $138M trimmed.
- Rockefeller Capital Management's largest Q4 2020 buy was BridgeBio Pharma: 777,031 shares worth $55.3M.
- Rockefeller Capital Management added most to Alibaba in Q4 2020, an estimated $120M increase.
- Rockefeller Capital Management's biggest Q4 2020 reduction was Progressive, cutting an estimated $138M.
- Rockefeller Capital Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $1.67M.
- Rockefeller Capital Management's ten largest holdings make up 24% of its $13.2B portfolio in Q4 2020.
- Rockefeller Capital Management opened 401 new positions and closed 168 in Q4 2020.
- Rockefeller Capital Management's portfolio value rose 24% quarter-over-quarter to $13.2B.
Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.